Points to consider regarding the SABR-COMET trial - Authors' reply
- PMID: 32035556
- DOI: 10.1016/S0140-6736(19)32557-7
Points to consider regarding the SABR-COMET trial - Authors' reply
Comment on
-
Points to consider regarding the SABR-COMET trial.Lancet. 2020 Feb 8;395(10222):e19. doi: 10.1016/S0140-6736(19)32494-8. Lancet. 2020. PMID: 32035555 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources